Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: August 7, 2025
Reporting Period: Fiscal Fourth Quarter ended June 30, 2025
Context: The Company issued a press release announcing preliminary, unaudited revenue results for the specified quarter.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that preliminary, unaudited revenue results have been issued in a separate press release (Exhibit 99.1), but the figures themselves are not contained within the body of this 8-K text.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in this filing text. The report references the issuance of preliminary results but does not quantify the variance from previous periods.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of preliminary, unaudited revenue results for Q4 2025.
Legal Disclaimer: The information contained in this report and its exhibits is not incorporated by reference into other filings and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Outlook/Guidance: No forward-looking guidance or specific risk factors are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2025) for the actual preliminary revenue figures.
- Verify the unaudited nature of the reported results before making investment decisions.
- Check subsequent filings for the audited financial statements for the fiscal year ended June 30, 2025.
- Confirm the Company's status as an emerging growth company and any related accounting standard elections.